Alleva Lawrence M
Insider CIK 1553053 · BFAM Director · MRSN Director · TSRO Director · MIRN Director · GRTX Director · ADAP Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GRTX Galera Therapeutics, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-05 | 240 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | D To issuer | 2026-08-03 | 2026-08-05 | 40 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | D To issuer | 2026-08-03 | 2026-08-05 | 11 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-05 | 240 | — | — | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | D To issuer | 2026-08-03 | 2026-08-05 | 40 | — | — | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | D To issuer | 2026-08-03 | 2026-08-05 | 11 | — | — | 0 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award | 2026-06-03 | 2026-06-05 | 2,096 | — | $0 | 13,336 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 500 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 384 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 734 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 215 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 181 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,800 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 546 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,002 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 133 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 368 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 450 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,000 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 544 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 400 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 142 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 800 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,460 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 358 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,200 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 159 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 310 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 561 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | U Tender | 2026-01-06 | 2026-01-06 | 84 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | U Tender | 2026-01-06 | 2026-01-06 | 578 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 61,500 | — | $0 | 61,500 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award | 2025-06-03 | 2025-06-05 | 976 | — | $0 | 11,240 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 48,000 | — | $0 | 48,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 12,521 | — | $0 | 12,521 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 9,615 | — | $0 | 9,615 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-07-01 | 2024-07-01 | 1,213,926 | — | $0 | 1,213,926 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-07-01 | 2024-07-02 | 8,972 | — | $0 | 8,972 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-06-11 | 2024-06-12 | 55,000 | — | $0 | 55,000 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award | 2024-06-05 | 2024-06-06 | 902 | — | $0 | 10,264 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-04-01 | 2024-04-03 | 3,996 | — | $0 | 3,996 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 7,763 | — | $0 | 7,763 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | S Sale | 2023-12-01 | 2023-12-01 | 680 | $88.59 | $60.2K | 9,362 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-10-02 | 2023-10-04 | 14,047 | — | $0 | 14,047 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-03 | 2023-07-03 | 1,077,756 | — | $0 | 1,077,756 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-07-03 | 2023-07-06 | 5,391 | — | $0 | 5,391 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2023-07-01 | 2023-07-05 | 22,762 | — | $0 | 22,762 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award | 2023-06-21 | 2023-06-22 | 1,087 | — | $0 | 10,042 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 48,000 | — | $0 | 48,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 18,355 | — | $0 | 18,355 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award | 2023-06-08 | 2023-06-12 | 14,467 | — | $0 | 14,467 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-04-03 | 2023-04-05 | 4,525 | — | $0 | 4,525 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | G Gift | 2022-07-18 | 2022-07-20 | 4,000 | — | $0 | 2,325 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-07-01 | 2022-07-01 | 816,067 | — | $0 | 816,067 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award | 2022-06-22 | 2022-06-23 | 1,299 | — | $0 | 8,955 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 13,657 | — | $0 | 13,657 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2021-07-01 | 2021-07-02 | 505,918 | — | $0 | 505,918 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2021-07-01 | 2021-07-06 | 8,498 | — | $0 | 8,498 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award | 2021-06-24 | 2021-06-28 | 671 | — | $0 | 7,656 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 9,888 | — | $0 | 9,888 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 25,050 | — | $0 | 25,050 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2021-06-01 | 2021-06-03 | 12,600 | $0.79 | $10.0K | 12,600 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2021-06-01 | 2021-06-03 | 4,045 | $8.59 | $34.7K | 4,045 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2021-06-01 | 2021-06-03 | 1,035 | $14.38 | $14.9K | 2,120 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 3,339 | — | $0 | 3,339 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2020-11-13 | 2020-11-17 | 2,325 | $10.22 | $23.8K | 6,325 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2020-07-01 | 2020-07-01 | 197,678 | — | $0 | 197,678 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2020-06-25 | 2020-06-29 | 9,200 | — | $0 | 9,200 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award | 2020-06-16 | 2020-06-17 | 801 | — | $0 | 6,985 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-10 | 9,888 | — | $0 | 9,888 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2020-06-09 | 2020-06-11 | 12,900 | $1.89 | $24.4K | 12,900 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2020-06-01 | 2020-06-03 | 700 | $22.94 | $16.1K | 1,085 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2020-06-01 | 2020-06-03 | 385 | $22.97 | $8.8K | 385 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | P Buy | 2020-05-19 | 2020-05-21 | 227 | $107.95 | $24.5K | 6,184 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | M Exercise deriv | 2020-05-11 | 2020-05-13 | 1,000 | — | $0 | 0 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | M Exercise | 2020-05-11 | 2020-05-13 | 1,000 | — | $0 | 5,957 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 11,264 | — | $0 | 11,264 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2019-12-13 | 2019-12-17 | 4,000 | $9.78 | $39.1K | 4,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-07-02 | 2019-07-03 | 271,209 | — | $0 | 271,209 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2019-06-07 | 2019-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award | 2019-05-29 | 2019-05-31 | 739 | — | $0 | 4,957 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | M Exercise deriv | 2019-05-12 | 2019-05-14 | 1,011 | — | $0 | 0 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | M Exercise | 2019-05-12 | 2019-05-14 | 1,011 | — | $0 | 4,218 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 12,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 10,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 12,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 7,209 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 10,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 21,428 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 4,052 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 10,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | U Tender | 2019-01-22 | 2019-01-22 | 29,902 | $75.00 | $2.24M | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2019-01-02 | 2019-01-04 | 13,619 | — | $0 | 13,619 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-12-17 | 2018-12-19 | 47,280 | $0.84 | $39.7K | 47,280 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2018-09-20 | 2018-09-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | M Exercise deriv | 2018-08-07 | 2018-08-07 | 2,272 | — | $0 | 0 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | M Exercise deriv | 2018-08-07 | 2018-08-07 | 3,000 | — | $0 | 0 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | S Sale | 2018-08-07 | 2018-08-07 | 1,248 | $110.37 | $137.7K | 3,207 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | S Sale | 2018-08-07 | 2018-08-07 | 6,424 | $109.81 | $705.4K | 4,455 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | M Exercise | 2018-08-07 | 2018-08-07 | 3,000 | $34.96 | $104.9K | 10,879 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | M Exercise | 2018-08-07 | 2018-08-07 | 2,272 | $22.00 | $50.0K | 7,879 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2018-06-22 | 2018-06-26 | 124,000 | — | $0 | 124,000 | SEC↗ |
| TSRO TESARO, Inc. | M Exercise deriv | 2018-06-12 | 2018-06-14 | 7,142 | — | $0 | 0 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award | 2018-06-12 | 2018-06-13 | 925 | — | $0 | 5,607 | SEC↗ |
| TSRO TESARO, Inc. | S Sale | 2018-06-12 | 2018-06-14 | 4,200 | $43.46 | $182.5K | 29,902 | SEC↗ |
| TSRO TESARO, Inc. | S Sale | 2018-06-12 | 2018-06-14 | 2,942 | $42.62 | $125.4K | 34,102 | SEC↗ |
| TSRO TESARO, Inc. | M Exercise | 2018-06-12 | 2018-06-14 | 7,142 | $6.62 | $47.3K | 37,044 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2018-06-01 | 2018-06-06 | 7,209 | — | $0 | 7,209 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2018-06-01 | 2018-06-06 | 4,052 | — | $0 | 4,052 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2018-06-01 | 2018-06-06 | 1,599 | — | $0 | 29,902 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2018-01-02 | 2018-01-04 | 3,560 | — | $0 | 3,560 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2017-09-05 | 2017-09-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2017-07-03 | 2017-07-03 | 243,724 | — | $0 | 243,724 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2017-06-01 | 2017-06-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award | 2017-06-01 | 2017-06-05 | 1,282 | — | $0 | 4,682 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2017-06-01 | 2017-06-05 | 469 | — | $0 | 28,303 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2016-08-11 | 2016-08-12 | 196,678 | — | $0 | 196,678 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | A Award deriv | 2016-06-29 | 2016-09-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2016-06-01 | 2016-06-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2016-06-01 | 2016-06-03 | 1,480 | — | $0 | 27,834 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award | 2016-05-12 | 2016-05-13 | 1,000 | — | $0 | 3,400 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-06 | 207 | — | $0 | 4,025 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-06 | 3,818 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-06 | 3,818 | — | $0 | 3,818 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | A Award deriv | 2015-09-30 | 2015-09-30 | 10,533 | — | $0 | 10,533 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2015-06-01 | 2015-06-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2015-06-01 | 2015-06-03 | 1,069 | — | $0 | 26,354 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award deriv | 2015-05-11 | 2015-05-13 | 1,000 | — | $0 | 1,000 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2014-09-29 | 2014-09-30 | 1,100 | $26.17 | $28.8K | 25,285 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2014-06-02 | 2014-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2014-06-02 | 2014-06-04 | 2,522 | — | $0 | 24,185 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award deriv | 2014-05-12 | 2014-05-14 | 1,011 | — | $0 | 1,011 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | P Buy | 2013-11-12 | 2013-11-27 | 1,400 | $35.36 | $49.5K | 2,400 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2013-07-31 | 2013-08-01 | 1,449 | $34.33 | $49.7K | 21,663 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2013-06-03 | 2013-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2013-06-03 | 2013-06-05 | 1,114 | — | $0 | 20,214 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award deriv | 2013-05-22 | 2013-05-24 | 3,000 | — | $0 | 3,000 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2013-04-30 | 2013-05-02 | 1,050 | $28.10 | $29.5K | 19,100 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | P Buy | 2013-01-30 | 2013-02-01 | 1,000 | $22.00 | $22.0K | 1,000 | SEC↗ |
| BFAM BRIGHT HORIZONS FAMILY SOL | A Award deriv | 2013-01-24 | 2013-01-28 | 2,272 | — | $0 | 2,272 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2012-11-01 | 2012-11-02 | 3,240 | $15.45 | $50.1K | 18,050 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2012-10-15 | 2012-10-17 | 3,329 | — | $0 | 14,810 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2012-07-03 | 2012-07-06 | 11,481 | $13.50 | $155.0K | 11,481 | SEC↗ |